Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine

Area of Science:

• Neuroscience
• Pharmacology
• Alzheimer's Disease Research

Background:

• Soluble amyloid-beta protein (Aβ) is implicated in Alzheimer's disease (AD) cognitive impairment, potentially independent of significant neurodegeneration.
• The role of N-methyl-D-aspartate receptors (NMDARs) in mediating rapid, Aβ-induced functional deficits is not fully understood.

Purpose of the Study:

• To investigate the neuroprotective potential of memantine, an NMDAR antagonist, against synthetic Aβ-induced deficits in synaptic plasticity and learned behavior in a rat model.
• To determine if NMDAR-dependent mechanisms underlie the acute cognitive impairments caused by soluble Aβ.

Main Methods:

• In vitro assessment of long-term potentiation (LTP) in the dentate gyrus following memantine and Aβ(1-42) exposure.
• In vivo evaluation of LTP in the CA1 area and performance in an operant learning task after systemic memantine and Aβ(1-42) administration.
• Utilized a clinically relevant concentration of memantine and subthreshold doses to assess its protective effects.

Main Results:

• In vitro, memantine partially inhibited LTP and prevented further Aβ(1-42)-induced inhibition.
• In vivo, a subthreshold dose of memantine partially abrogated Aβ(1-42)-induced LTP inhibition in the CA1 area.
• Memantine alone impaired learning, but a subthreshold dose prevented Aβ(1-42)-induced increases in learning task errors.

Conclusions:

• Acute administration of memantine demonstrates protective effects against rapid, Aβ(1-42)-induced functional deficits in synaptic plasticity and learned behavior.
• These findings strongly implicate NMDAR-dependent reversible synaptic dysfunction as a key mechanism in Aβ-mediated cognitive impairment in Alzheimer's disease.